Public Sector Pension Investment Board Grows Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Key Points

• The Public Sector Pension Investment Board has increased its stake in Prestige Consumer Healthcare Inc. by 44.6%, bringing its total shares to 178,019, valued at approximately $15.3 million.
• Most analysts currently rate Prestige Consumer Healthcare with a consensus of "Hold," with a recent price target range from $100.00 to $93.33.
• For the last quarter, the company reported earnings per share of $0.95, below the expected $1.01, with a year-over-year revenue decline of 6.6%.

Public Sector Pension Investment Board boosted its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 44.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 178,019 shares of the company's stock after purchasing an additional 54,926 shares during the period. Public Sector Pension Investment Board owned about 0.36% of Prestige Consumer Healthcare worth $15,304,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in PBH. Opal Wealth Advisors LLC acquired a new position in Prestige Consumer Healthcare in the 1st quarter worth $38,000. McIlrath & Eck LLC raised its holdings in shares of Prestige Consumer Healthcare by 19.1% in the 4th quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock valued at $75,000 after purchasing an additional 154 shares during the period. Johnson Financial Group Inc. acquired a new position in Prestige Consumer Healthcare in the 4th quarter valued at about $93,000. Costello Asset Management INC acquired a new position in Prestige Consumer Healthcare in the 1st quarter valued at about $112,000. Finally, Sterling Capital Management LLC grew its position in shares of Prestige Consumer Healthcare by 837.1% during the 4th quarter. Sterling Capital Management LLC now owns 1,593 shares of the company's stock worth $124,000 after purchasing an additional 1,423 shares in the last quarter. Institutional investors own 99.95% of the company's stock.

Prestige Consumer Healthcare Price Performance

PBH stock traded up $0.46 during trading on Friday, hitting $65.06. 698,764 shares of the company's stock traded hands, compared to its average volume of 512,360. Prestige Consumer Healthcare Inc. has a 52 week low of $62.95 and a 52 week high of $90.04. The stock has a market capitalization of $3.20 billion, a price-to-earnings ratio of 15.27, a P/E/G ratio of 2.05 and a beta of 0.43. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.99 and a current ratio of 4.38. The business has a fifty day simple moving average of $77.27 and a 200 day simple moving average of $81.60.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.95 EPS for the quarter, missing analysts' consensus estimates of $1.01 by ($0.06). The company had revenue of $249.53 million during the quarter, compared to analyst estimates of $260.71 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%. The firm's revenue for the quarter was down 6.6% on a year-over-year basis. During the same quarter last year, the business earned $0.90 earnings per share. As a group, research analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on PBH. Wall Street Zen lowered shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Royal Bank Of Canada upgraded shares of Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Finally, Canaccord Genuity Group reduced their price objective on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating for the company in a research report on Friday, August 8th. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, Prestige Consumer Healthcare has an average rating of "Hold" and an average target price of $93.33.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.